The U.S. Senate Appropriations Committee has raised concerns over marijuana’s status as a Schedule 1 drug amid efforts to remove the plant from the government’s list of controlled substances. “The Committee is concerned that restrictions associated with Schedule 1 of the Controlled Substance Act effectively limit the amount and type of research that can be […]